Hoey Investments’s Ginkgo Bioworks DNA Stock Holding History

Hoey Investments’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$399	Hold	65	–	–	﹤0.01%	383
2025 Q4	$541	Hold	65	–	–	﹤0.01%	384
2025 Q3	$948	Hold	65	–	–	﹤0.01%	356
2025 Q2	$732	Hold	65	–	–	﹤0.01%	369
2025 Q1	$371	Hold	65	–	–	﹤0.01%	342
2024 Q4	$639	Sell	65 -935	-94%	-$8.01K	﹤0.01%	326
2024 Q3	$335	Buy	1,000 +975	+3,900%	+$9.77K	﹤0.01%	367
2024 Q2	$335	Hold	25	–	–	﹤0.01%	367
2024 Q1	$1.16K	Hold	25	–	–	﹤0.01%	310
2023 Q4	$1.69K	Hold	25	–	–	﹤0.01%	302
2023 Q3	$1.81K	Hold	25	–	–	﹤0.01%	305
2023 Q2	$1.86K	Hold	25	–	–	﹤0.01%	300
2023 Q1	$1.33K	Hold	25	–	–	﹤0.01%	309
2022 Q4	$1.69K	Hold	25	–	–	﹤0.01%	267
2022 Q3	$3K	Hold	25	–	–	﹤0.01%	278
2022 Q2	$2K	Buy	+25	New	+$3.05K	﹤0.01%	252

Other funds holding DNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Legal & General Group

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return